S. 43: Skinny Labels, Big Savings Act

S. 43 is a federal bill in the 119th Congress. Before this bill, generic drug companies could get Food and Drug Administration approval to sell medications for specific unpatented uses while other uses remained protected by patents, a practice known as skinny labeling. However, recent court rulings… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.